According to Curevac's latest financial reports the company has a price-to-book ratio of 3.67.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 1.87 | -77.3% |
2021-12-31 | 8.23 | -50.11% |
2020-12-31 | 16.5 | INF% |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | 1.08 | -70.59% | ๐บ๐ธ USA |